• This activity is jointly sponsored by the University of Wisconsin-Madison School of Pharmacy and CME Enterprise. It was originally presented as a Satellite Symposium during the 2006 Annual Meeting of the American College of Clinical Pharmacy in St. Louis, Missouri.
• Estimated Time: 2 hours
• Price: $0
• Release Date: May 25, 2007
• Expiration Date: May 24, 2008
• Supported by an educational grant from Wyeth.

This activity is jointly sponsored by the University of Wisconsin-Madison School of Pharmacy and CME Enterprise and is supported by an educational grant from Wyeth. Activity content was developed independently by the faculty. The opinions or views expressed in this CE activity are those of the presenters and do not necessarily reflect the opinions or recommendations of the sponsor or commercial supporter.

Welcome and Overview
Steven C. Ebert, PharmD, FCCP, BCPS-ID
Program Chairperson
Clinical Specialist, Infectious Diseases
Clinical Supervisor, Department of Pharmacy
Meriter Hospital
Clinical Professor,
University of Wisconsin School of Pharmacy
Madison, Wisconsin

Antimicrobial Resistance Prevalence
Dennis G. Maki, MD
Ovid O. Meyer Professor of Medicine,
Head, Section of Infectious Diseases
University of Wisconsin School of Medicine and Public Health
Madison, Wisconsin

Current Treatment Environment
Steven C. Ebert, PharmD, FCCP, BCPS-ID
Program Chairperson

Antimicrobial Stewardship
Michael J. Rybak, PharmD, MPH, FCCP, FIDSA
Associate Dean for Research,
Eugene Applebaum College of Pharmacy and Health Sciences
Professor of Pharmacy Practice,
Adjunct Professor of Medicine, Division of Infectious Diseases
College of Pharmacy and Allied Health Professions
Wayne State University
Detroit, Michigan

Case Study and Panel Discussion

Question and Answer Session

Listening to the complete Web Cast will take approximately 2 hours. An additional 15 minutes (approximately) will be needed to complete the posttest and evaluation. There are no prerequisites for participants.

This activity is designed for clinical pharmacists involved in infectious disease management decisions and integrating antimicrobial resistance programs in their practice settings.

As members of the interdisciplinary healthcare team, clinical pharmacists need to take an active role in their healthcare setting to assist in the implementation of the CDC 12-step program to reduce the risk of antimicrobial resistance. The activity will begin with a review of antimicrobial resistance in healthcare settings. The faculty will then discuss recommendations for appropriate treatment of infection based on the clinician's diagnostic criteria. Faculty will provide information for the participants to better educate the interdisciplinary healthcare team and integrate the CDC 12-Step Campaign to Prevent Antimicrobial Resistance into their setting. Faculty will instruct the participants on ways to monitor the inappropriate use of antibiotics and how to share these findings with the clinicians in order to reduce antimicrobial resistance. A case study and a question and answer session will conclude the activity.

Upon completion of the activity, participants should be able to

1. Describe the prevalence of antimicrobial resistance in healthcare settings.
2. Recommend appropriate treatment of infection based on the diagnostic criteria provided by the clinician.
3. Educate interdisciplinary healthcare team members on the CDC 12-Step Campaign to Prevent Antimicrobial Resistance.
4. Integrate the CDC 12-Step Campaign to Prevent Antimicrobial Resistance into the practice setting.
5. Monitor inappropriate use of antibiotics and share findings with clinicians in order to reduce antimicrobial resistance.

All faculty are required to disclose to the audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the educational activity. The faculty disclosure statements are listed below.

Steven C. Ebert, PharmD, FCCP, BCPS-ID

Dr. Ebert serves as a speaker for Pfizer Inc. and Wyeth Pharmaceuticals. His presentation will not include discussion of off-label, experimental, or investigational uses of drugs or devices.

Dennis G. Maki, MD

Dr. Maki has no relevant relationships to disclose in regard to this activity. His presentation will not include discussion of off-label, experimental, or investigational uses of drugs or devices.

Michael J. Rybak, PharmD, MPH, FCCP

Dr. Rybak receives honoraria from and serves as a consultant for Cubist Pharmaceuticals, Elan, Schering-Plough, Theravance/Astellas, and Wyeth Pharmaceuticals. His presentation will not include discussion of off-label, experimental, or investigational uses of drugs or devices.

Extension Services in Pharmacy at the University of Wisconsin-Madison School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This program has been approved for a maximum of 2 hours (0.2 CEUs) of pharmacy continuing education credit. A Statement of Credit will be provided online to those who successfully complete this program as documented through online completion of a posttest and an activity evaluation. Those who participated in and received continuing education credit for the October 26, 2006, program on antimicrobial resistance conducted at the 2006 Annual Meeting of the American College of Clinical Pharmacy or who have participated in and received credit from the supplement derived from this program that is published in the Pharmacotherapy journal are not eligible for duplicate CE credit for this program.

  Universal program #073-999-07-074-H01

Jointly sponsored by the University of Wisconsin-Madison School of Pharmacy and CME Enterprise

   

Supported by an educational grant from Wyeth

How Do I Receive My Credit?

After participating in the Web cast, click on the link provided under the evaluation section below, and you will be redirected to the University of Wisconsin-Madison School of Pharmacy Web site to complete this program and earn CE credit. You will be instructed to log in to complete the posttest and the activity evaluation in order to receive a Statement of Credit online. The Web cast for this CE activity is available to view at your convenience 24 hours a day, 7 days a week through May 24, 2008. If you have questions, you may contact the University of Wisconsin-Madison School of Pharmacy CE office (ie, Extension Services in Pharmacy) directly at 608.262.3130.

There Is No Fee to Participate in This Activity

©2007 The University of Wisconsin-Madison School of Pharmacy

Please click on the below link to be automatically redirected to UW-School of Pharmacy’s Web site to complete the evaluation and posttest:

http://www.pharmacy.wisc.edu/esp/antimicrobialresistanceaccp

The content of this online program, including slides, audio, and handouts, are the intellectual property of the American College of Clinical Pharmacy, and its presenters. This material may not be recorded, reproduced, stored in a retrieval system, transmitted, or transcribed, in any form or by any means, electronic or mechanical, including photocopy, without the express written permission of the American College of Clinical Pharmacy, and its presenters.